|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash and cash equivalents ($525 and $532 restricted cash, respectively) | ||||||||||||
| Accounts receivable ($4,254 and $2,533 related party, respectively) | ||||||||||||
| Contract assets | ||||||||||||
| Deferred transaction costs | ||||||||||||
| Other current assets ($5,332 and $983 related party, respectively) | ||||||||||||
| Total current assets | ||||||||||||
| Investments and advances to equity method investments | ||||||||||||
| Operating lease right-of-use assets | ||||||||||||
| Property and equipment, net | ||||||||||||
| Intangible assets, net | ||||||||||||
| Other non-current assets | ||||||||||||
| Total assets | ||||||||||||
| Liabilities and Equity | ||||||||||||
| Accounts payable ($149 and $215 related party, respectively) | ||||||||||||
| Short-term advances ($1,500 and $0 related party as of June 30, 2025 and December 31, 2024, respectively) | ||||||||||||
| Accrued expenses and other current liabilities ($348 and $501 related party, respectively) | ||||||||||||
| Contract liabilities | ||||||||||||
| Operating lease liability, current | ||||||||||||
| Short-term debt ($636 and $1,386 related party, respectively) | ||||||||||||
| Long-term debt, current | ||||||||||||
| Earnout liabilities – current portion | ||||||||||||
| Total current liabilities | ||||||||||||
| Operating lease liability, net of current portion | ||||||||||||
| Other long term payables | ||||||||||||
| Long-term debt, net of current portion ($7,563 and $5,024 related party, respectively) | ||||||||||||
| Earnout liabilities, net of current portion | ||||||||||||
| Warrant liabilities | ||||||||||||
| Class A Common Stock | ||||||||||||
| Total warrant liabilities | ||||||||||||
| Total liabilities | ||||||||||||
| Stockholders' equity | ||||||||||||
| Series B preferred stock ($0.0001 par value, 8,000,000 shares authorized; 7,086,960 and 6,715,721 issued and outstanding as of June 30, 2026 and December 31, 2025, respectively; Liquidation preference of $35.4 million and $33.6 million as of June 30, 2026 and December 31, 2025, respectively) | ||||||||||||
| Common stock, value | ||||||||||||
| Class A Common Stock | ||||||||||||
| Class B Common Stock | ||||||||||||
| Total common stock, value | ||||||||||||
| Due from stockholder | ||||||||||||
| Additional paid-in capital | ||||||||||||
| Accumulated deficit | ||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||
| Total equity attributable to common stockholders | ||||||||||||
| Noncontrolling interest | ||||||||||||
| Total equity | ||||||||||||
| Total liabilities and equity |
Loading...
